Skip to main content
PMC home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1993 Feb;46(2):149–153. doi: 10.1136/jcp.46.2.149

Prognostic value of epidermal growth factor receptor expression in cervical carcinoma.

R J Hale 1, C H Buckley 1, W J Gullick 1, H Fox 1, J Williams 1, F L Wilcox 1
PMCID: PMC501147  PMID: 8459036

Abstract

AIMS: To investigate the pattern of epidermal growth factor receptor expression and its prognostic value in the three main types of cervical carcinoma. METHODS: 62 cases of stage IB/IIA cervical carcinoma, all with a minimum of five years of follow up, were studied. Representative sections were stained for mucin to permit accurate tumour typing and a standard avidin-biotin immunoperoxidase technique using the polyclonal antibody 12E was used to demonstrate the presence of epidermal growth factor receptor. RESULTS: A proportion of all three tumour types expressed epidermal growth factor receptor, it being most common in squamous cell carcinomas (50%). Overall, there was a correlation between epidermal growth factor expression and mortality. This was particularly obvious in the absence of lymph node metastases. When the individual tumour types were considered this association with prognosis was not demonstrable for squamous cell carcinomas or adenocarcinomas but was a very prominent feature of adenosquamous carcinomas. CONCLUSIONS: Immunohistochemical demonstration of epidermal growth factor receptor expression may be useful in identifying those patients with a poor prognosis, particularly those with adenosquamous carcinomas which have not metastasised to the regional lymph nodes.

Full text

PDF
152

Images in this article

151Image
on p.151
151Image
on p.151

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Battaglia F., Scambia G., Benedetti Panici P., Baiocchi G., Perrone L., Iacobelli S., Mancuso S. Epidermal growth factor receptor expression in gynecological malignancies. Gynecol Obstet Invest. 1989;27(1):42–44. doi: 10.1159/000293614. [DOI] [PubMed] [Google Scholar]
  2. Bauknecht T., Kohler M., Janz I., Pfleiderer A. The occurrence of epidermal growth factor receptors and the characterization of EGF-like factors in human ovarian, endometrial, cervical and breast cancer. EGF receptors and factors in gynecological carcinomas. J Cancer Res Clin Oncol. 1989;115(2):193–199. doi: 10.1007/BF00397923. [DOI] [PubMed] [Google Scholar]
  3. Berchuck A., Rodriguez G., Kamel A., Soper J. T., Clarke-Pearson D. L., Bast R. C., Jr Expression of epidermal growth factor receptor and HER-2/neu in normal and neoplastic cervix, vulva, and vagina. Obstet Gynecol. 1990 Sep;76(3 Pt 1):381–387. [PubMed] [Google Scholar]
  4. COHEN S. Isolation of a mouse submaxillary gland protein accelerating incisor eruption and eyelid opening in the new-born animal. J Biol Chem. 1962 May;237:1555–1562. [PubMed] [Google Scholar]
  5. Carpenter G., Cohen S. Epidermal growth factor. Annu Rev Biochem. 1979;48:193–216. doi: 10.1146/annurev.bi.48.070179.001205. [DOI] [PubMed] [Google Scholar]
  6. Carpenter G., Zendegui J. G. Epidermal growth factor, its receptor, and related proteins. Exp Cell Res. 1986 May;164(1):1–10. doi: 10.1016/0014-4827(86)90449-0. [DOI] [PubMed] [Google Scholar]
  7. Cohen S. The epidermal growth factor (EGF). Cancer. 1983 May 15;51(10):1787–1791. doi: 10.1002/1097-0142(19830515)51:10<1787::aid-cncr2820511004>3.0.co;2-a. [DOI] [PubMed] [Google Scholar]
  8. Cooper J. A., Bowen-Pope D. F., Raines E., Ross R., Hunter T. Similar effects of platelet-derived growth factor and epidermal growth factor on the phosphorylation of tyrosine in cellular proteins. Cell. 1982 Nov;31(1):263–273. doi: 10.1016/0092-8674(82)90426-3. [DOI] [PubMed] [Google Scholar]
  9. Fitzpatrick S. L., Brightwell J., Wittliff J. L., Barrows G. H., Schultz G. S. Epidermal growth factor binding by breast tumor biopsies and relationship to estrogen receptor and progestin receptor levels. Cancer Res. 1984 Aug;44(8):3448–3453. [PubMed] [Google Scholar]
  10. Fitzpatrick S. L., LaChance M. P., Schultz G. S. Characterization of epidermal growth factor receptor and action on human breast cancer cells in culture. Cancer Res. 1984 Aug;44(8):3442–3447. [PubMed] [Google Scholar]
  11. Gullick W. J., Hughes C. M., Mellon K., Neal D. E., Lemoine N. R. Immunohistochemical detection of the epidermal growth factor receptor in paraffin-embedded human tissues. J Pathol. 1991 Aug;164(4):285–289. doi: 10.1002/path.1711640403. [DOI] [PubMed] [Google Scholar]
  12. Gullick W. J., Marsden J. J., Whittle N., Ward B., Bobrow L., Waterfield M. D. Expression of epidermal growth factor receptors on human cervical, ovarian, and vulval carcinomas. Cancer Res. 1986 Jan;46(1):285–292. [PubMed] [Google Scholar]
  13. Gusterson B., Cowley G., Smith J. A., Ozanne B. Cellular localisation of human epidermal growth factor receptor. Cell Biol Int Rep. 1984 Aug;8(8):649–658. doi: 10.1016/0309-1651(84)90045-6. [DOI] [PubMed] [Google Scholar]
  14. Hale R. J., Buckley C. H., Fox H., Williams J. Prognostic value of c-erbB-2 expression in uterine cervical carcinoma. J Clin Pathol. 1992 Jul;45(7):594–596. doi: 10.1136/jcp.45.7.594. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Hayashi Y., Hachisuga T., Iwasaka T., Fukuda K., Okuma Y., Yokoyama M., Sugimori H. Expression of ras oncogene product and EGF receptor in cervical squamous cell carcinomas and its relationship to lymph node involvement. Gynecol Oncol. 1991 Feb;40(2):147–151. doi: 10.1016/0090-8258(91)90107-g. [DOI] [PubMed] [Google Scholar]
  16. Horne G. M., Angus B., Wright C., Needham G., Nicholson S., Harris A. L., Innes B., Horne C. H. Relationships between oestrogen receptor,epidermal growth factor receptor, ER-D5, and P24 oestrogen regulated protein in human breast cancer. J Pathol. 1988 Jun;155(2):143–150. doi: 10.1002/path.1711550211. [DOI] [PubMed] [Google Scholar]
  17. Imai Y., Leung C. K., Friesen H. G., Shiu R. P. Epidermal growth factor receptors and effect of epidermal growth factor on growth of human breast cancer cells in long-term tissue culture. Cancer Res. 1982 Nov;42(11):4394–4398. [PubMed] [Google Scholar]
  18. Kohler M., Janz I., Wintzer H. O., Wagner E., Bauknecht T. The expression of EGF receptors, EGF-like factors and c-myc in ovarian and cervical carcinomas and their potential clinical significance. Anticancer Res. 1989 Nov-Dec;9(6):1537–1547. [PubMed] [Google Scholar]
  19. Nicholson S., Sainsbury J. R., Needham G. K., Chambers P., Farndon J. R., Harris A. L. Quantitative assays of epidermal growth factor receptor in human breast cancer: cut-off points of clinical relevance. Int J Cancer. 1988 Jul 15;42(1):36–41. doi: 10.1002/ijc.2910420108. [DOI] [PubMed] [Google Scholar]
  20. Ozanne B., Richards C. S., Hendler F., Burns D., Gusterson B. Over-expression of the EGF receptor is a hallmark of squamous cell carcinomas. J Pathol. 1986 May;149(1):9–14. doi: 10.1002/path.1711490104. [DOI] [PubMed] [Google Scholar]
  21. Pfeiffer D., Stellwag B., Pfeiffer A., Borlinghaus P., Meier W., Scheidel P. Clinical implications of the epidermal growth factor receptor in the squamous cell carcinoma of the uterine cervix. Gynecol Oncol. 1989 May;33(2):146–150. doi: 10.1016/0090-8258(89)90540-4. [DOI] [PubMed] [Google Scholar]
  22. Pérez R., Pascual M., Macías A., Lage A. Epidermal growth factor receptors in human breast cancer. Breast Cancer Res Treat. 1984;4(3):189–193. doi: 10.1007/BF01806484. [DOI] [PubMed] [Google Scholar]
  23. Real F. X., Rettig W. J., Chesa P. G., Melamed M. R., Old L. J., Mendelsohn J. Expression of epidermal growth factor receptor in human cultured cells and tissues: relationship to cell lineage and stage of differentiation. Cancer Res. 1986 Sep;46(9):4726–4731. [PubMed] [Google Scholar]
  24. Sainsbury J. R., Farndon J. R., Needham G. K., Malcolm A. J., Harris A. L. Epidermal-growth-factor receptor status as predictor of early recurrence of and death from breast cancer. Lancet. 1987 Jun 20;1(8547):1398–1402. doi: 10.1016/s0140-6736(87)90593-9. [DOI] [PubMed] [Google Scholar]
  25. Shoyab M., Plowman G. D., McDonald V. L., Bradley J. G., Todaro G. J. Structure and function of human amphiregulin: a member of the epidermal growth factor family. Science. 1989 Feb 24;243(4894 Pt 1):1074–1076. doi: 10.1126/science.2466334. [DOI] [PubMed] [Google Scholar]
  26. Tonelli Q. J., Sorof S. Epidermal growth factor requirement for development of cultured mammary gland. Nature. 1980 May 22;285(5762):250–252. doi: 10.1038/285250a0. [DOI] [PubMed] [Google Scholar]
  27. Ushiro H., Cohen S. Identification of phosphotyrosine as a product of epidermal growth factor-activated protein kinase in A-431 cell membranes. J Biol Chem. 1980 Sep 25;255(18):8363–8365. [PubMed] [Google Scholar]
  28. Wrba F., Reiner A., Ritzinger E., Holzner J. H., Reiner G. Expression of epidermal growth factor receptors (EGFR) on breast carcinomas in relation to growth fractions, estrogen receptor status and morphological criteria. An immunohistochemical study. Pathol Res Pract. 1988 Feb;183(1):25–29. [PubMed] [Google Scholar]
  29. Wright C., Angus B., Napier J., Wetherall M., Udagawa Y., Sainsbury J. R., Johnston S., Carpenter F., Horne C. H. Prognostic factors in breast cancer: immunohistochemical staining for SP1 and NCRC 11 related to survival, tumour epidermal growth factor receptor and oestrogen receptor status. J Pathol. 1987 Dec;153(4):325–331. doi: 10.1002/path.1711530406. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES